Impact of vaccination on dengue transmission: an epidemiological model
DOI:
https://doi.org/10.5902/2179460X90552Keywords:
Dengue vaccination, SIR model, Dengue epidemiology, Vaccination coverage, Dengue transmission dynamicsAbstract
This study analyzes the impact of vaccination on dengue transmission using an epidemiological model of the SIR (Susceptible-Infected-Recovered) type. The model considers interactions between humans and vectors, and control strategies such as vaccination and mosquito population management. The results show a substantial reduction in dengue cases with vaccination, reinforcing its importance as an essential tool for public health. Recent data and simulations developed supported the conclusions, highlighting the role of mathematical models in the development of effective policies.
Downloads
References
Amorim, M. P. (2020). Modelos Matem´aticos e Computacionais da Dengue via Equaç˜oes Diferenciais Ordin´arias com Estrat´egias de Controle. [Dissertac¸ ˜ao de Mestrado, Programa de P´os-Graduac¸ ˜ao em Modelagem Computacional em Ciˆencia e Tecnologia, Universidade Federal Fluminense]. Reposit´orio Institucional UNESP.
Brady, O. J., Gething, P. W., Bhatt, S., Messina, J. P., Brownstein, J. S., Hoen, A. G., Moyes, C. L., Farlow, A. W., Scott, T. W., & Hay, S. I. (2015). Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Neglected Tropical Diseases, 9(8):e0003657.
Coudeville, L. & Garnett, G. (2012). Transmission dynamics of the four dengue serotypes in southern vietnam and the potential impact of vaccination. Plos One, 7(12).
DeRoeck, D., Deen, J., & J, D. C. (2003). Policymakers’ views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast asian countries. Vaccine, 22(1):121–9.
Farrington, C. P. (2003). On vaccine efficacy and reproduction numbers. Mathematical Biosciences, 185(1):89–109.
Giesecke, J. (2017). Modern Infectious Disease Epidemiology. CRC/Press.
Kall´as, E. G., Cintra, M. A., Moreira, J. A., Pati˜no, E. G., Braga, P. E., Ten´orio, J. C., & Infante, V. (2024). Live, attenuated, tetravalent butantan–dengue vaccine in children and adults. The New England Journal of Medicine, 390(5):397–408.
Knipl, D. & Moghadas, S. (2015). The potential impact of vaccination on the dynamics of dengue infections. Bulletin of Mathematical Biology, 77(12):2212–2230.
Kurauchi, M. L. (2020). Modelagem do efeito de uma vacina contra a dengue na redução da evolução da resistˆencia contra o antibi´otico devido uso inadequado em casos de dengue. [Tese de Doutorado, Programa de Patologia da Faculdade de Medicina, Universidade de S˜ao Paulo]. Reposit´orio da Produção USP.
Kwon, S. (2023). Nonequilibrium phase transitions in metapopulation models of infectious diseases on heterogeneous networks. Journal of Physics a Mathematical and Theoretical, 56(37).
Lourenço, J. & Recker, M. (2016). Dengue serotype immune-interactions and their consequences for vaccine impact predictions. Epidemics, 16:40–48.
Lowe, R., S. Lee, K. O., Brady, O., Bastos, L., Carrasco-Escobar, G., Cat˜ao, R. C., Col´on-Gonz´alez, F., Barcellos, C., Carvalho, M. S., Blangiardo, M., Rue, H., & Gasparrini,
A. (2021). Combined effects of hydrometeorological hazards and urbanisation on dengue risk in brazil: a spatiotemporal modelling study. The Lancet Planetary Health, 5(4):e209–e219.
Messina, J. P., Brady, O. J., Golding, N., Kraemer, M. U. G., Wint, G. R. W., Ray, S. E., Pigott, D. M., Shearer, F. M., Johnson, K., & Earl, L. (2019). The current and future global distribution and population at risk of dengue. Nature Microbiology, 4(9):1508–1515.
Milunovic, M. & Krsti´c, M. (2022). Long time behavior of an two diffusion stochastic sir epidemic model with nonlinear incidence and treatment. Filomat, 36(8):2829–2846.
Ndii, M., Mage, A., Messakh, J., & Djahi, B. (2020). Optimal vaccination strategy for dengue transmission in kupang city, indonesia. Heliyon, 6(11):e05345.
Reich, N., Shrestha, S., King, A., Rohani, P., Lessler, J., Kalayanarooj, S., Yoon, I.-K., Gibbons, R. V., Burke, D. S., & Cummings, D. (2013). Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. Journal of the Royal Society Interface, 10(86):20130414.
Rodrigues, H. S. (2012). Optimal control and numerical optimization applied to epidemiological models. [Tese de Doutorado, Programa Doutoral em Matem´atica e Aplicaç˜oes, Universidade de Aveiro e Universidade de Minho]. arXiv.
Rodrigues, H. S., Monteiro, M. T. T., & Torres, M. D. F. (2014). Vaccination models and optimal control strategies to dengue. Mathematical Biosciences, 247:1–12.
Rodriguez-Barraquer, I., y Teran-Romero, L. M., Schwartz, I., Burke, D., & Cummings, D. (2014). Potential opportunities and perils of imperfect dengue vaccines. Vaccine, 32(4):514–520.
Scherer, A. & McLean, A. (2002). Mathematical models of vaccination. British Medical Bulletin, 62(1):187–199
Shepard, D. S., Undurraga, E. A., Halasa, Y. A., & Stanaway, J. D. (2016). The global economic burden of dengue: A systematic analysis. The Lancet Infectious Diseases, 16(8):935–941.
Shim, E. (2017). Cost-effectiveness of dengue vaccination in yucat´an, mexico using a dynamic dengue transmission model. Plos One, 12(4):e0175020.
Suwantika, A., Supadmi, W., Ali, M., & Abdulah, R. (2021). Cost-effectiveness and budget impact analyses of dengue vaccination in indonesia. Plos Neglected Tropical Diseases, 15(8).
Tang, B., Xi, H., Xiao, Y., Ruan, S., & Wu, J. (2018). A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement. Theoretical Biology and Medical Modelling, 15(13):1–19.
Thisyakorn, U., Saokaew, S., Gallagher, E., Kastner, R., Sruamsiri, R., Oliver, L., & Hanley, R. (2022). Epidemiology and costs of dengue in thailand: a systematic literature review. Plos Neglected Tropical Diseases, 16(12):e0010966.
Thome, R. C., Yang, H. M., & Esteva, L. (2010). Optimal control of aedes aegypti mosquitoes by the sterile technique and insecticide. Mathematical Biosciences, 223:12–23.
WHO (2023). Dengue and severe dengue.
Wilder-Smith, A., Ooi, E. E., Horstick, O., & Wills, B. (2019). Dengue. The Lancet, 393(10169): 350–363.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ciência e Natura
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
To access the DECLARATION AND TRANSFER OF COPYRIGHT AUTHOR’S DECLARATION AND COPYRIGHT LICENSE click here.
Ethical Guidelines for Journal Publication
The Ciência e Natura journal is committed to ensuring ethics in publication and quality of articles.
Conformance to standards of ethical behavior is therefore expected of all parties involved: Authors, Editors, Reviewers, and the Publisher.
In particular,
Authors: Authors should present an objective discussion of the significance of research work as well as sufficient detail and references to permit others to replicate the experiments. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. Review Articles should also be objective, comprehensive, and accurate accounts of the state of the art. The Authors should ensure that their work is entirely original works, and if the work and/or words of others have been used, this has been appropriately acknowledged. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. Authors should not submit articles describing essentially the same research to more than one journal. The corresponding Author should ensure that there is a full consensus of all Co-authors in approving the final version of the paper and its submission for publication.
Editors: Editors should evaluate manuscripts exclusively on the basis of their academic merit. An Editor must not use unpublished information in the editor's own research without the express written consent of the Author. Editors should take reasonable responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper.
Reviewers: Any manuscripts received for review must be treated as confidential documents. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should be conducted objectively, and observations should be formulated clearly with supporting arguments, so that Authors can use them for improving the paper. Any selected Reviewer who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the Editor and excuse himself from the review process. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
